OCT Therapies
(OCT THERAPIES AND RESEARCH PRIVATE LIMITED)
Founded in 2013
About OCT Therapies
Oct Therapies is a startup that specializes in the development of innovative solutions for burns and ulcers. They establish a mesenchymal stem cell bank using allogenic mesenchymal stem cells, offering a cell-based approach to wound healing.
Incubators & Accelerators of OCT Therapies
Public Links of OCT Therapies
Frequently Asked Questions (FAQ)
When was OCT Therapies founded?
OCT Therapies was founded in the year 2013.
What is the legal name of OCT Therapies?
The legal name of OCT Therapies is Oct Therapies And Research Private Limited.
Who are the founders of OCT Therapies?
OCT Therapies is founded by Caroline Evette Mathen, Caroline Mathen and Mathen M.
Which Incubators & Accelerators supported OCT Therapies?
What are the focus areas of OCT Therapies?
Who are OCT Therapies's competitors?
Possible competitors of OCT Therapies may include Adb, Apace Syscorp Private Limited, Exocan Healthcare Technologies and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
